Dr. Sridevi Khambhampaty Appointed As CEO Of Shilpa Biologicals

Dr. Sridevi Khambhampaty has been appointed as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited, with effect from September 19, 2024.

Dr. Sridevi Khambhampaty brings an overall technocommercial experience of 22+ years in various organisations, notably the Lymphoma & Leukaemia Research Foundation, Dr. Reddy’s, and Intas Pharmaceuticals. Her most recent assignment was with Syngene International Ltd. She has a PhD in Biophysics from NCBS-TIFR Bangalore and also has a postdoctoral fellowship from Stanford University, California.